Market Cap

Karolinska Development AB Market Capitalization:

kr472.5 Million

SEK as of Jan. 1, 2024

US$46.9 Million

business Karolinska Development AB Company Profile

Karolinska Development AB Main Stock Listing

OMX: KDEV

Market Capitalization History of Karolinska Development AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Karolinska Development AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr472.5 M -16.29%
Jan. 1, 2023 kr564.5 M -53.77%
Jan. 1, 2022 kr1.22 B 149.13%
Jan. 1, 2021 kr490.1 M -52.62%
Jan. 1, 2020 kr1.03 B -44.15%
Jan. 1, 2019 kr1.85 B 22.64%
Jan. 1, 2018 kr1.51 B -10.17%
Jan. 1, 2017 kr1.68 B -36.90%
Jan. 1, 2016 kr2.66 B -21.43%
Jan. 1, 2015 kr3.39 B -50.62%
Jan. 1, 2014 kr6.87 B 26.18%
Jan. 1, 2013 kr5.44 B -18.03%
Jan. 1, 2012 kr6.64 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Karolinska Development AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Karolinska Development AB has the following listings and related stock indices.


Stock: OMX: KDEV

Stock: FSX: 2I9

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.